SCHEMBL216321

SCHEMBL216321

C=C(C)C(=O)OCc1c2ccccc2cc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.49
HTR2A P28223 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GPR35 Q9HC97 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.38
EDNRA P25101 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.37
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625710 1.00 EPHX1 (0.49) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL13048901 0.94 EPHX1 (0.45) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL2014907 0.91 EPHX1 (0.43) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL12903610 0.89 EPHX1 (0.39) EPHX1KMT2AMEN1ALDH1A1HPGD
SCHEMBL16271329 0.89 TSHR (0.41) EPHX1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL8065282 0.87 THRB (0.46) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL5071502 0.85 KMT2A (0.42) EPHX1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL5594535 0.85 RAD52 (0.45) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL2222008 0.83 EPHX1 (0.54) EPHX1HTR2AL3MBTL1KMT2AMEN1
SCHEMBL31326117 0.83 EPHX1 (0.54) EPHX1HTR2AL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 870 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243389-A1 COMPOSITION COMPRISING ADDITIVE HAVING A POLYCYCLIC AROMATIC GROUP E INK CORPORATION 2025-07-31 US claimed
CN-117820776-A Polymer-based composite material with low dielectric constant and low dielectric loss, and preparation method and application thereof 四川大学 2024-04-05 CN claimed
CN-117431023-A Lead plaster and preparation process of RGO with double surface modification 泉州市凯鹰电源电器有限公司 2024-01-23 CN claimed
CN-117417476-A Modified polyacrylic resin, preparation method thereof and photoresist 广东粤港澳大湾区黄埔材料研究院 2024-01-19 CN claimed
CN-116200149-B Preparation process of functionalized graphene adhesive for negative electrode of lead-carbon battery 泉州市凯鹰电源电器有限公司 2023-09-08 CN claimed
CN-116200149-A Preparation process of functionalized graphene adhesive for negative electrode of lead-carbon battery 泉州市凯鹰电源电器有限公司 2023-06-02 CN claimed
CN-109794849-B Polishing pad with pad wear indicator 罗门哈斯电子材料CMP控股股份有限公司 2021-12-21 CN claimed
US-11205778-B2 Conductive polymer emulsion THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-12-21 US claimed
CN-106901871-B Intraocular lens with one or more additional portions 爱博诺德(北京)医疗科技股份有限公司 2021-08-24 CN claimed
CN-109794850-B Polishing pad with multi-purpose composite window 罗门哈斯电子材料CMP控股股份有限公司 2021-08-13 CN claimed
WO-2003058345-A2 NEGATIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING CLARIANT INTERNATIONAL LTD (CH) 2003-07-17 WO claimed
WO-2003057678-A1 POSITIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING CLARIANT INTERNATIONAL LTD (CH) 2003-07-17 WO claimed
US-20030129547-A1 Process for producing an image using a first minimum bottom antireflective coating composition MERCK PATENT GMBH (DE) 2003-07-10 US claimed
US-20030129531-A1 Positive-working photoimageable bottom antireflective coating MERCK PATENT GMBH (DE) 2003-07-10 US claimed
EP-1309360-A2 MEDICAMENT INCORPORATION MATRIX SurModics, Inc. (US) 2003-05-14 EP claimed
EP-0808855-B1 Fluorescent polymers and coating compositions ROHM & HAAS (US) 2002-07-17 EP claimed
US-20020041899-A1 Medicament incorporation matrix Surmodics Coatings, LLC 2002-04-11 US claimed
WO-2002013871-A2 MEDICAMENT INCORPORATION MATRIX SURMODICS, INC. (US) 2002-02-21 WO claimed
US-6344654-B1 AN ETHYLENICALLY UNSATURATED MONOMER IS COPOLYMERIZED WITH A POLYNUCLEAR AROMATIC HYDROCARBON OR A SUBSTITUTED AROMATIC DERIVATIVE THEREOF, SUCH THAT THE RESULTANT POLYMER IS FLUORESCENT. ROHM AND HAAS COMPANY 2002-02-05 US claimed
EP-0808855-A2 Fluorescent polymers and coating compositions ROHM AND HAAS COMPANY (US) 1997-11-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020041899-A1 Medicament incorporation matrix COL14A1, MATR3, ECPAS EPHX1 2473/4885HTR2A 1551/4885L3MBTL1 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.